Most Undervalued Stocks

Our fundamental package is one which includes our most undervalued stocks answering a number of fundamental criteria. The package includes forecasts for short term stocks to buy with high and low of each of the four basic valuation indicators of quantitative trading based on a self-learning algorithm:

• P/E (price to earnings ratio)
• PEG (price/earnings to growth ratio)
• price-to-book ratio
• price-to-sales ratio

Our algorithms help you find best opportunities for both long and short positions in stocks within each fundamental screen.

Package Name: Fundamental – Low P/E Ratio Stocks
Forecast Length: 7 Days (9/13/16– 09/20/16)
I Know First Average: 8.88%

8 out of 10 stocks in the long position for this 7 days forecast increased as predicted by the algorithm. The highest returning stock for the short-term was Northwest Biotherapeutics, Inc. (NWBO). The stock rose impressively by 74.75%. The next top performer was Navidea Biopharmaceuticals, Inc. (NAVB).  The stock returned 13.79%.  The package’s overall growth was 8.88%.  The S&P 500’s return was -0.89% for the same time period.  The market premium calculates to 9.77%.

Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology company developing treatments for cancer patients, such as their product: DCVax.  The company seeks to develop personalized vaccines without the side effects of chemotherapy drugs.  The FDA is in the midst of deciding whether or not to approve some of their products.  The CEO is Linda F. Powers.  The company was founded in 1996 and headquartered in Bethesda, Maryland.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.